SLC22A8 and obesity disorder: There were no obviousdifferences in aztreonam and avibactam exposures correlating with obesity(defined as body mass index ≥30 kg/m2) andnon-obesity, China and non-China (rest of world), or organic anion transporter(OAT)1/OAT3 inhibitor comedications (data not shown).